Persistent Link:
http://hdl.handle.net/10150/245084
Title:
Pharmaceuticals in Southern Arizona
Author:
Hernandez, Abdel
Issue Date:
May-2012
Publisher:
The University of Arizona.
Rights:
Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
Abstract:
The pharmaceutical industry is a potentially powerful but untapped industry in Southern Arizona. One such company in this industry is Topical Technologies, which develops topical solutions to treat skin cancer, and was founded by University of Arizona Cancer Center researchers. We conducted our primary research in the form of one-on-one interviews with diverse experts in a variety of fields; Dr. Robert Dorr, Co-Founder of Topical Technologies, Dr. Steve Stratton, Associate Professor of Medicine at AZCC, Robert Morrison, the Executive Director of the Desert Angels, Marie Wesselhoft, former Director of the Arizona Center for Innovation, and Dr. Debra Hanna, Associate Director of C-Path. We also conducted secondary research into the pharmaceutical industry. After conducting our research and analyzing the data, we formulated several recommendations to Tech Launch Arizona including: *Fostering relationships between the University leadership, business school, and BIO5 Institute *Forming long-term relationships with corporations *Building a venture portfolio that invests in multiple industries *Partnering with the Critical Path Institute We believe these recommendations will help create a more efficient environment for pharmaceutical companies to be successful.
Type:
text; Electronic Thesis
Degree Name:
B.S.B.A.
Degree Level:
bachelors
Degree Program:
Honors College; Entrepreneurship
Degree Grantor:
University of Arizona

Full metadata record

DC FieldValue Language
dc.language.isoenen_US
dc.titlePharmaceuticals in Southern Arizonaen_US
dc.creatorHernandez, Abdelen_US
dc.contributor.authorHernandez, Abdelen_US
dc.date.issued2012-05-
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.description.abstractThe pharmaceutical industry is a potentially powerful but untapped industry in Southern Arizona. One such company in this industry is Topical Technologies, which develops topical solutions to treat skin cancer, and was founded by University of Arizona Cancer Center researchers. We conducted our primary research in the form of one-on-one interviews with diverse experts in a variety of fields; Dr. Robert Dorr, Co-Founder of Topical Technologies, Dr. Steve Stratton, Associate Professor of Medicine at AZCC, Robert Morrison, the Executive Director of the Desert Angels, Marie Wesselhoft, former Director of the Arizona Center for Innovation, and Dr. Debra Hanna, Associate Director of C-Path. We also conducted secondary research into the pharmaceutical industry. After conducting our research and analyzing the data, we formulated several recommendations to Tech Launch Arizona including: *Fostering relationships between the University leadership, business school, and BIO5 Institute *Forming long-term relationships with corporations *Building a venture portfolio that invests in multiple industries *Partnering with the Critical Path Institute We believe these recommendations will help create a more efficient environment for pharmaceutical companies to be successful.en_US
dc.typetexten_US
dc.typeElectronic Thesisen_US
thesis.degree.nameB.S.B.A.en_US
thesis.degree.levelbachelorsen_US
thesis.degree.disciplineHonors Collegeen_US
thesis.degree.disciplineEntrepreneurshipen_US
thesis.degree.grantorUniversity of Arizonaen_US
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.